Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Avoiding Monsters: Weighing Recipient Risk and Donor Quality in Lung Transplantation.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 20, 2026
The changing face of lung transplant candidates.
Journal: Current opinion in pulmonary medicine
Published: May 18, 2026
Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: February 02, 2026
Are donor-specific antibodies really all that "baseline lung allograft dysfunction"?
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: June 25, 2025
CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: March 26, 2025
"Probable Chronic Lung Allograft Dysfunction" Is Definitely Good Enough.
Journal: American journal of respiratory and critical care medicine
Published: December 19, 2024
North American expert consensus on the clinical role of ex vivo lung perfusion (EVLP) with acellular perfusate.
Journal: Journal of thoracic disease
Published: December 18, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Journal: Research square
Published: March 11, 2024
Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for Lymphangioleiomyomatosis.
Journal: Chest
Published: February 26, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
Journal: BMC pulmonary medicine
Published: February 16, 2024
Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.
Journal: Transplantation
Published: January 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: October 25, 2023
Last Updated: 09/26/2026